Future Medicine Co., Ltd. (XKON: 341170)

Future Medicine Statistics

Total Valuation

Future Medicine has a market cap or net worth of KRW 16.69 billion.

Market Cap	16.69B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Future Medicine has 9.28 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	9.28M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+35.88%
Owned by Insiders (%)	15.35%
Owned by Institutions (%)	3.90%
Float	7.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.69
PB Ratio	2.56
P/TBV Ratio	2.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.62, with a Debt / Equity ratio of 0.03.

Current Ratio	9.62
Quick Ratio	9.08
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.03
Interest Coverage	-4.55

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	38.46M
Profits Per Employee	-514.10M
Employee Count	26
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.91% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-72.91%
50-Day Moving Average	2,362.82
200-Day Moving Average	3,621.94
Relative Strength Index (RSI)	27.86
Average Volume (20 Days)	1,388

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Future Medicine had revenue of KRW 1.00 billion and -13.37 billion in losses. Loss per share was -1,637.42.

Revenue	1.00B
Gross Profit	1.00B
Operating Income	-7.09B
Pretax Income	-13.37B
Net Income	-13.37B
EBITDA	-6.64B
EBIT	-7.09B
Loss Per Share	-1,637.42

Balance Sheet

The company has 5.41 billion in cash and 226.27 million in debt, giving a net cash position of 5.18 billion or 558.86 per share.

Cash & Cash Equivalents	5.41B
Total Debt	226.27M
Net Cash	5.18B
Net Cash Per Share	558.86
Equity (Book Value)	6.52B
Book Value Per Share	703.11
Working Capital	5.21B

Cash Flow

In the last 12 months, operating cash flow was -7.09 billion and capital expenditures -110.72 million, giving a free cash flow of -7.20 billion.

Operating Cash Flow	-7.09B
Capital Expenditures	-110.72M
Free Cash Flow	-7.20B
FCF Per Share	-776.78

Margins

Gross Margin	100.00%
Operating Margin	-708.92%
Pretax Margin	-1,336.67%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-720.50%

Dividends & Yields

Future Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-91.02%
FCF Yield	-43.18%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Future Medicine has an Altman Z-Score of -10.89. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.89
Piotroski F-Score	n/a